Emerging Technologies and Therapeutics for Type 1 Diabetes
Akturk, H.K., McKee, A KEY POINTS Diabetes technologies are evolving, and new generation continuous glucose monitors and hybrid-closed loop systems…
The promise of Diabetes Technologies: Clinical Diabetology
Ebekozien, O, Hardison, H, Shah, V. There is a wide discrepancy in the diabetes care, availability of diabetes technologies and…
REDUCED ODDS OF DIABETIC KETOACIDOSIS AMONG HYBRID CLOSED LOOP SYSTEM (HCLS) USERS: PROPENSITY SCORE MATCH OF 8,455 PEOPLE WITH TYPE 1 DIABETES
Ebekozien, O, Demeterco-Berggren, C, Clements, M, Majidi, S, Malik, F, Hsieh, S, Haw, S, Kamboj, M, Noor, N. Background and…
Patient-Reported Severe Hypoglycemia Among Hybrid Closed Loop System (HCLS) Users: Real Word Evidence
Ebekozien, O, Noor, N, Lee, J, Izquierdo, R, Golden, L, Miyazaki, B, Wilkes, M, Scott, M, Mekhoubad, A, Sanchez, J….
Hybrid Closed-Loop Systems and Glycemic Outcomes in Children and Adults With Type 1 Diabetes: Real-World Evidence From a U.S.-Based Multicenter Collaborative
Noor, N, Kamboj, M, Triolo, T, Polsky, S, McDonough, R, Demeterco-Berggren, C, Jacobsen, L, Sonabend, L, Ebekozien, O, DeSalvo, D…
Hybrid Closed Loop Systems and Glycemic Outcomes in Children and Adults with Type 1 Diabetes: Real World Evidence From U.S. Based Multi-Center Collaborative
DeSalvo, D, Ebekozien, O, Ospelt, E, Kamboj, M, Cobry, E, Polsky, S, Izquierdo, R, McDonough, R, Ogburn, S, Demeterco-Berggren, C,…
